What is the share price of India Glycols Ltd (INDIAGLYCO) today?
The share price of INDIAGLYCO as on 13th June 2025 is ₹1889.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on India Glycols Ltd (INDIAGLYCO) share?
The past returns of India Glycols Ltd (INDIAGLYCO) share are- Past 1 week: -3.43%
- Past 1 month: 16.14%
- Past 3 months: 76.37%
- Past 6 months: 36.36%
- Past 1 year: 108.29%
- Past 3 years: 164.15%
- Past 5 years: 562.40%
What are the peers or stocks similar to India Glycols Ltd (INDIAGLYCO)?
The peers or stocks similar to India Glycols Ltd (INDIAGLYCO) include:What is the dividend yield % of India Glycols Ltd (INDIAGLYCO) share?
The current dividend yield of India Glycols Ltd (INDIAGLYCO) is 0.53.What is the market cap of India Glycols Ltd (INDIAGLYCO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of India Glycols Ltd (INDIAGLYCO) is ₹5842.45 Cr as of 13th June 2025.What is the 52 week high and low of India Glycols Ltd (INDIAGLYCO) share?
The 52-week high of India Glycols Ltd (INDIAGLYCO) is ₹1948.50 and the 52-week low is ₹867.75.What is the PE and PB ratio of India Glycols Ltd (INDIAGLYCO) stock?
The P/E (price-to-earnings) ratio of India Glycols Ltd (INDIAGLYCO) is 25.30. The P/B (price-to-book) ratio is 2.85.Which sector does India Glycols Ltd (INDIAGLYCO) belong to?
India Glycols Ltd (INDIAGLYCO) belongs to the Materials sector & Commodity Chemicals sub-sector.How to buy India Glycols Ltd (INDIAGLYCO) shares?
You can directly buy India Glycols Ltd (INDIAGLYCO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
India Glycols Ltd
INDIAGLYCO Share Price
1,889.504.59% (+83.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
INDIAGLYCO Performance & Key Metrics
INDIAGLYCO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 25.30 | 2.85 | 0.53% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 27.19 | 3.46 | 1.60% |
INDIAGLYCO Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
INDIAGLYCO Company Profile
India Glycols Limited is a company engaged in the manufacturing of technology-based bulk, specialty and performance chemicals, natural gums, spirits, industrial gases, sugar and nutraceuticals.
SOLARINDS
PE Ratio
125.90
125.90
1Y Return
73.01%
73.01%
Buy Reco %
80.00
80.00
LINDEINDIA
PE Ratio
133.62
133.62
1Y Return
23.09%
23.09%
Buy Reco %
50.00
50.00
DEEPAKNTR
PE Ratio
37.31
37.31
1Y Return
20.59%
20.59%
Buy Reco %
60.00
60.00
SUMICHEM
PE Ratio
48.78
48.78
1Y Return
1.19%
1.19%
Buy Reco %
100.00
100.00
PE Ratio
41.67
41.67
1Y Return
30.10%
30.10%
Buy Reco %
100.00
100.00
INDIAGLYCO Sentiment Analysis
INDIAGLYCO Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
INDIAGLYCO Stock Summary · May 2025
The company has demonstrated robust growth, particularly in the Bio-Fuels and Potable Spirits segments, with net revenue and profit after tax significantly increasing due to strong demand and effective capacity utilization. However, challenges persist in the Chemicals segment, where pricing pressures have led to stagnation, necessitating a strategic focus on core operations. Management remains optimistic about future growth, particularly through premiumization strategies in the IMFL market and ongoing government support for ethanol production, which is expected to enhance farmer incomes and stabilize raw material supply. Despite operational challenges, the company is well-positioned to leverage its market strengths and maintain profitability, reflecting a positive outlook for sustained growth across its key segments.
INDIAGLYCO Stock Growth Drivers
INDIAGLYCO Stock Growth Drivers
8Strong Financial Performance
India Glycols Limited has reported significant financial achievements, including a net revenue increase to INR
Growth in Key Segments
The company has experienced remarkable growth in its key segments. The Bio-Fuels segment surged by
INDIAGLYCO Stock Challenges
INDIAGLYCO Stock Challenges
3Decline in Bio-based Specialties and Performance Chemicals Segment
The Bio-based Specialties and Performance Chemicals segment has reported a significant decline, with net revenue
Challenges in Joint Venture Performance
Concerns have been raised regarding the impact of fluctuating crude prices on joint venture performance.
INDIAGLYCO Forecast
INDIAGLYCO Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
INDIAGLYCO
INDIAGLYCO
Income
Balance Sheet
Cash Flow
Annual Normal View
INDIAGLYCO Income Statement
INDIAGLYCO Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,507.01 | 3,057.44 | 3,373.51 | 2,784.03 | 2,355.38 | 3,570.55 | 2,714.26 | 3,336.36 | 3,829.21 | 3,829.21 | ||||||||||
Raw Materials | 1,486.25 | 1,830.87 | 1,913.88 | 1,673.94 | 1,354.14 | 1,811.50 | 1,338.44 | 1,797.24 | 3,257.32 | 3,257.32 | ||||||||||
| Power & Fuel Cost | 288.99 | 335.55 | 410.41 | 250.34 | 213.93 | 332.08 | 417.47 | 328.44 | ||||||||||||
| Employee Cost | 96.04 | 97.06 | 100.84 | 93.28 | 83.33 | 89.16 | 88.80 | 103.37 | ||||||||||||
| Selling & Administrative Expenses | 177.52 | 173.28 | 186.90 | 128.32 | 130.65 | 156.06 | 113.95 | 146.54 | ||||||||||||
| Operating & Other expenses | 214.50 | 275.28 | 328.64 | 311.18 | 266.94 | 652.52 | 396.67 | 516.03 | ||||||||||||
EBITDA | 243.71 | 345.40 | 432.84 | 326.97 | 306.39 | 529.23 | 358.93 | 444.74 | 571.89 | 571.89 | ||||||||||
| Depreciation/Amortization | 72.04 | 73.10 | 76.24 | 77.53 | 80.12 | 80.29 | 93.96 | 100.77 | 115.20 | 115.20 | ||||||||||
| PBIT | 171.67 | 272.30 | 356.60 | 249.44 | 226.27 | 448.94 | 264.97 | 343.97 | 456.69 | 456.69 | ||||||||||
| Interest & Other Items | 126.68 | 125.14 | 143.48 | 96.90 | 83.38 | 69.66 | 99.96 | 120.67 | 164.37 | 164.37 | ||||||||||
| PBT | 44.99 | 147.16 | 213.12 | 152.54 | 142.89 | 379.28 | 165.01 | 223.30 | 292.32 | 292.32 | ||||||||||
| Taxes & Other Items | 9.95 | 50.63 | 80.51 | 37.87 | 11.28 | 39.43 | 39.92 | 50.32 | 61.40 | 61.40 | ||||||||||
| Net Income | 35.04 | 96.53 | 132.61 | 114.67 | 131.61 | 339.85 | 125.09 | 172.98 | 230.92 | 230.92 | ||||||||||
| EPS | 11.32 | 31.18 | 42.83 | 37.04 | 42.51 | 109.77 | 40.40 | 55.87 | 74.58 | 74.58 | ||||||||||
| DPS | 1.00 | 4.00 | 6.00 | 6.00 | 6.00 | 7.50 | 7.50 | 8.00 | 10.00 | 8.00 | ||||||||||
| Payout ratio | 0.09 | 0.13 | 0.14 | 0.16 | 0.14 | 0.07 | 0.19 | 0.14 | 0.13 | 0.11 |
INDIAGLYCO Company Updates
FY 2025FY 2025
Investor Presentation
May 21PDF
Feb 6PDF
INDIAGLYCO Stock Peers
INDIAGLYCO Past Performance & Peer Comparison
INDIAGLYCO Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsCommodity Chemicals
Compare valuation on Screener
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| India Glycols Ltd | 25.30 | 2.85 | 0.53% |
| Solar Industries India Ltd | 125.90 | 44.43 | 0.06% |
| Linde India Ltd | 133.62 | 17.52 | — |
| Deepak Nitrite Ltd | 37.31 | 5.39 | 0.39% |
INDIAGLYCO Stock Price Comparison
Compare INDIAGLYCO with any stock or ETFCompare INDIAGLYCO with any stock or ETF
INDIAGLYCO
INDIAGLYCO Holdings
INDIAGLYCO Shareholdings
INDIAGLYCO Promoter Holdings Trend
INDIAGLYCO Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
INDIAGLYCO Institutional Holdings Trend
INDIAGLYCO Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
INDIAGLYCO Shareholding Pattern
INDIAGLYCO Shareholding Pattern
INDIAGLYCO Shareholding History
INDIAGLYCO Shareholding History
Foreign Institutions
Mutual Funds Invested in INDIAGLYCO
Mutual Funds Invested in INDIAGLYCO
Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has decreased by 1.75%
Top 5 Mutual Funds holding India Glycols Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1181% | Percentage of the fund’s portfolio invested in the stock 0.29% | Change in the portfolio weight of the stock over the last 3 months 0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 33/318 (+3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0775% | Percentage of the fund’s portfolio invested in the stock 2.80% | Change in the portfolio weight of the stock over the last 3 months 2.80% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 15/57 (+31) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0198% | Percentage of the fund’s portfolio invested in the stock 0.32% | Change in the portfolio weight of the stock over the last 3 months 0.32% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 46/123 (+1) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing INDIAGLYCO stock
smallcases containing INDIAGLYCO stock
Looks like this stock is not in any smallcase yet.
INDIAGLYCO Events
INDIAGLYCO Events
INDIAGLYCO Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INDIAGLYCO has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.53%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹5.30 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
INDIAGLYCO Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INDIAGLYCO has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.53%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹5.30 every year
INDIAGLYCO Upcoming Dividends
INDIAGLYCO Upcoming Dividends
No upcoming dividends are available
INDIAGLYCO Past Dividends
INDIAGLYCO Past Dividends
Cash Dividend
Ex DateEx DateAug 21, 2024
Final
Final | Div/Share: ₹8.00
Dividend/Share
₹8.00
Ex DateEx Date
Aug 21, 2024
Cash Dividend
Ex DateEx DateSep 5, 2023
Final
Final | Div/Share: ₹7.50
Dividend/Share
₹7.50
Ex DateEx Date
Sep 5, 2023
Cash Dividend
Ex DateEx DateAug 29, 2022
Final
Final | Div/Share: ₹7.50
Dividend/Share
₹7.50
Ex DateEx Date
Aug 29, 2022
Cash Dividend
Ex DateEx DateSep 16, 2021
Final
Final | Div/Share: ₹6.00
Dividend/Share
₹6.00
Ex DateEx Date
Sep 16, 2021
Cash Dividend
Ex DateEx DateMar 11, 2020
Interim
Interim | Div/Share: ₹6.00
Dividend/Share
₹6.00
Ex DateEx Date
Mar 11, 2020
INDIAGLYCO Stock News & Opinions
INDIAGLYCO Stock News & Opinions
Articles & Videos
Corporate
Board of India Glycols approves sub-division of equity shares
The Board of India Glycols at its meeting held on 30 May 2025 has approved sub-division of equity shares of the company of face value of Rs 10 each into two equity shares of Rs 5 each. Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
India Glycols to conduct board meeting
India Glycols will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Board of India Glycols recommends final dividend
India Glycols announced that the Board of Directors of the Company at its meeting held on 16 May 2025, inter alia, have recommended the final dividend of Rs 10 per equity Share (i.e. 100%) , subject to the approval of the shareholders.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Earnings
India Glycols consolidated net profit rises 51.67% in the March 2025 quarter
Net profit of India Glycols rose 51.67% to Rs 64.02 crore in the quarter ended March 2025 as against Rs 42.21 crore during the previous quarter ended March 2024. Sales declined 6.79% to Rs 863.22 crore in the quarter ended March 2025 as against Rs 926.14 crore during the previous quarter ended March 2024. For the full year,net profit rose 33.49% to Rs 230.92 crore in the year ended March 2025 as against Rs 172.99 crore during the previous year ended March 2024. Sales rose 14.40% to Rs 3768.26 crore in the year ended March 2025 as against Rs 3293.97 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales863.22926.14 -7 3768.263293.97 14 OPM %16.9111.29 -13.5612.22 - PBDT114.3881.64 40 407.52324.08 26 PBT81.7955.60 47 292.32223.31 31 NP64.0242.21 52 230.92172.99 33 Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Earnings
India Glycols standalone net profit rises 33.41% in the March 2025 quarter
Net profit of India Glycols rose 33.41% to Rs 50.35 crore in the quarter ended March 2025 as against Rs 37.74 crore during the previous quarter ended March 2024. Sales declined 6.61% to Rs 862.57 crore in the quarter ended March 2025 as against Rs 923.63 crore during the previous quarter ended March 2024. For the full year,net profit rose 18.88% to Rs 180.38 crore in the year ended March 2025 as against Rs 151.73 crore during the previous year ended March 2024. Sales rose 14.46% to Rs 3767.13 crore in the year ended March 2025 as against Rs 3291.20 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales862.57923.63 -7 3767.133291.20 14 OPM %16.6511.38 -13.4512.09 - PBDT100.7177.16 31 356.97302.81 18 PBT68.1251.13 33 241.78202.05 20 NP50.3537.74 33 180.38151.73 19 Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
India Glycols to convene board meeting
India Glycols will hold a meeting of the Board of Directors of the Company on 16 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
India Glycols consolidated net profit rises 36.46% in the December 2024 quarter
Net profit of India Glycols rose 36.46% to Rs 56.81 crore in the quarter ended December 2024 as against Rs 41.63 crore during the previous quarter ended December 2023. Sales rose 7.85% to Rs 975.20 crore in the quarter ended December 2024 as against Rs 904.22 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales975.20904.22 8 OPM %12.6811.31 - PBDT98.8980.13 23 PBT71.4253.89 33 NP56.8141.63 36 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
India Glycols to conduct board meeting
India Glycols will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Spotlight
India Glycols incorporates subsidiary in India
The company will initially subscribe to 10,000 equity shares at face value of Rs 10 each aggregating to Rs 1,00,000 in cash. The company will carry on business of spirits and related products. India Glycols (IGL) manufactures green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. IGL operates under three broad segments: bio-based specialities & performance chemicals (BSPC), potable spirits (PS) and ennature biopharma (EB). The company's consolidated net profit jumped 30.8% on 24.1% increase in revenue from operations to Rs 961.20 crore in Q2 FY25 over Q2 FY24. The counter rallied 3.29% to end at Rs 1196.85 on Tuesday, 26 November 2024. Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
India Glycols incorporates wholly owned subsidiary - IGL Spirits
India Glycols has incorporated 'IGL Spirits' as its wholly owned subsidiary Company on 25 November 2024. Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -0.22%, vs industry avg of 8.53%
Over the last 5 years, market share decreased from 4.63% to 2.46%
Over the last 5 years, net income has grown at a yearly rate of 5.46%, vs industry avg of 0.64%